Cite
HARVARD Citation
Bonnevaux, H. et al. (2021). Pre-clinical development of a novel CD3-CD123 bispecific T-cell engager using cross-over dual-variable domain (CODV) format for acute myeloid leukemia (AML) treatment. Oncoimmunology. p. . [Online].